Hematology Analyzer BHA3601 3-Part Double Channel

Name: Hematology Analyzer BHA3601 3-Part Double Channel
Brand: Benemed (Hongkong) Industry Co., Limited
SKU: 764239222

Henan, ChinaBenemed (Hongkong) Industry Co., Limited

US$1,000.00-2,580.00

1 Piece

Product profile

Customization

Available

Classification

Biochemical Apparatus

Type

Urine Analyzer

Model NO.

BHA3601

Certification

CE, ISO13485

Group

All

N.W.

20kg

Display

8.4 Inch High Resolution TFT

Parameters

3-Part, 20 Parameters and 3 Histograms

Channel

Double

Storage

up to 100000 Samples

Throughput

up to 60 Samples/Hour

Reagent

Diluent, Rinse, Lyse

System

Open System

Printer

Thermal Printer, External Printer

Power

AC 100-240V, 50/60 Hz

Transport Package

Carton with Foam, Wooden Box

Specification

41*43*47cm

Trademark

BENEMED

Origin

China

HS Code

9027809900

Production Capacity

1000units/ Month

Company profile

High Repeat Buyers ChoiceFast DeliveryLow MOQOEM Services

Benemed (Hongkong) Industry Co., Limited

Henan, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2008-03-07Nearest Port: Shanghai/Ningbo/Qingdao/Shenzhen/ZhengzhouAverage Response Time: ≤5.24hTerms of Payment: LC, T/T, Western Union, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, EXW

AI-Powered supplier vetting

SummaryBenemed (Hongkong) Industry Co., Limited is identified as a China-based limited company in Henan operating as both a trading company and manufacturer/factory, with a broad medical-equipment portfolio. It reports annual hematology analyzer productivity of 5,000 pieces, export sales of 71%–90%, and broad international markets, with stated lead times of within 15 working days off-peak and one month during peak periods. The supplier offers multiple customization options, ODM, and OEM services, but reports no new products in the past year and no available SDK. Service-control documentation is weak: complaint handling and corrective/preventive action procedures or records were not available. Sustainability-related fire-drill and environmental-assessment statuses, raw-material traceability, and detailed financial condition are not sufficiently evidenced. A TUV Rheinland audit is listed, but the provided information does not specify certification status or audit findings.

Supplier typeThe supplier is described as a trading company and manufacturer/factory, legally organized as a limited company in China, with an address in Zhengzhou, Henan. Its stated business scope includes sales of Class I medical devices and related equipment, while its product portfolio covers multiple medical-device categories.

After-Sales capabilityThe supplier has relevant service records and provided some approved-supplier names, but it lacks written procedures or records for corrective and preventive actions and customer-complaint handling. This is explicit evidence of weak documented service controls.

R&D capabilityThe supplier reports no available SDK and no new products launched in the past year. It does provide ODM and OEM services, but these service offerings do not establish recent product innovation or software-development capability.

Production capacityAnnual productivity is stated as 5,000 hematology analyzers, and the supplier reports lead times within 15 working days off-peak and one month during peak season. Its broad product scope and stated factory status support production capability, although the information does not establish capacity for every listed product.

Customization capabilityThe supplier explicitly offers customization from samples, designs, full customization, minor customization, and flexible customization, and also reports ODM and OEM services. These statements directly support a broad customization offering.